Schedule 13G ownership disclosure

Eleven Biotherapeutics, Inc.

Security class unavailable · CUSIP: 286221106

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,449,337
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-079873
Form type
SC 13G/A
Filer
Carisma Therapeutics Inc.
CIK
CIK 1485003
Filed
Feb 09, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub